BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36847755)

  • 1. Comparison of T Lymphocyte Subsets and Natural Killer Lymphocytes in Moderate Versus Severe COVID-19 Patients.
    Gabr H; Abdel Aal AA; Bastawy S; Fateen M; Abd El Dayem OY; Youssef EA; Afifi R; Kamal M
    Viral Immunol; 2023 May; 36(4):250-258. PubMed ID: 36847755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
    Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
    BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the correlation between lymphocyte subsets and severity of corona virus disease 19].
    Bao F; Shi WL; Hu J; Zhang D; Gao DH; Xia YX; Jing HM; Ke XY; Ge QG; Shen N
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1075-1081. PubMed ID: 33331316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Exhaustion Levels of NK and CD8
    Li M; Guo W; Dong Y; Wang X; Dai D; Liu X; Wu Y; Li M; Zhang W; Zhou H; Zhang Z; Lin L; Kang Z; Yu T; Tian C; Qin R; Gui Y; Jiang F; Fan H; Heissmeyer V; Sarapultsev A; Wang L; Luo S; Hu D
    Front Immunol; 2020; 11():580237. PubMed ID: 33154753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of lymphocyte subset alterations in COVID-19 patients with different levels of disease severity.
    Dai W; Zhong A; Qiao Q; Wu J; Li W; Wu Q; Zhou H; Qin S; Jiang W; Zhang J; Xia X
    Virol J; 2022 Nov; 19(1):192. PubMed ID: 36403042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19.
    Pan P; Du X; Zhou Q; Cui Y; Deng X; Liu C; Hu Z; Chen J; Yu X; Shi W
    Virol J; 2022 Mar; 19(1):57. PubMed ID: 35346253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19.
    Yan L; Cai B; Li Y; Wang MJ; An YF; Deng R; Li DD; Wang LC; Xu H; Gao XD; Wang LL
    J Cell Mol Med; 2020 Dec; 24(24):14270-14279. PubMed ID: 33145962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphopenia with Altered T Cell Subsets in Hospitalized COVID-19 Patients in Pune, India.
    Suryawanshi P; Takbhate B; Athavale P; Jali P; Memane N; Mirza S; Karandikar M; Kakrani AL; Kanitkar S; Gandham N; Barthwal MS; Dole S; Chaturvedi S; Pawale S; Tripathy A; Bhawalkar JS; Tripathy S
    Viral Immunol; 2023 Apr; 36(3):163-175. PubMed ID: 36897333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.
    Liu J; Li S; Liu J; Liang B; Wang X; Wang H; Li W; Tong Q; Yi J; Zhao L; Xiong L; Guo C; Tian J; Luo J; Yao J; Pang R; Shen H; Peng C; Liu T; Zhang Q; Wu J; Xu L; Lu S; Wang B; Weng Z; Han C; Zhu H; Zhou R; Zhou H; Chen X; Ye P; Zhu B; Wang L; Zhou W; He S; He Y; Jie S; Wei P; Zhang J; Lu Y; Wang W; Zhang L; Li L; Zhou F; Wang J; Dittmer U; Lu M; Hu Y; Yang D; Zheng X
    EBioMedicine; 2020 May; 55():102763. PubMed ID: 32361250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
    Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis.
    Huang W; Berube J; McNamara M; Saksena S; Hartman M; Arshad T; Bornheimer SJ; O'Gorman M
    Cytometry A; 2020 Aug; 97(8):772-776. PubMed ID: 32542842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of NKG2A inhibitory receptor on cytotoxic lymphocytes as an indicator of severity in Corona Virus Disease 2019 (COVID-19) patients.
    Yasin MM; Shehata IH; Elsheikh NG; Elsayed MS
    Egypt J Immunol; 2021 Jul; 28(3):157-167. PubMed ID: 34453787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte subsets with the lowest decline at baseline and the slow lowest rise during recovery in COVID-19 critical illness patients with diabetes mellitus.
    Liu D; Lan L; Luo D; Zhao B; Wei G; He Y; Zhang R; Liu Y
    Diabetes Res Clin Pract; 2020 Sep; 167():108341. PubMed ID: 32707212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death.
    Belaid B; Lamara Mahammad L; Mihi B; Rahali SY; Djidjeli A; Larab Z; Berkani L; Berkane I; Sayah W; Merah F; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Ayoub S; Hamidi RM; Derrar F; Gharnaout M; Allam I; Djidjik R
    J Leukoc Biol; 2022 Jan; 111(1):269-281. PubMed ID: 33527487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early immune responses and prognostic factors in children with COVID-19: a single-center retrospective analysis.
    Lu W; Yang L; Li X; Sun M; Zhang A; Qi S; Chen Z; Zhang L; Li J; Xiong H
    BMC Pediatr; 2021 Apr; 21(1):181. PubMed ID: 33865340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in B and NK cells highly correlate with disease severity in children with COVID-19.
    Topyildiz E; Edeer Karaca N; Taşkin B; Aygün A; Şahbudak Bal Z; Saz EU; Kurugöl NZ; Kütükçüler N; Aksu G
    Turk J Med Sci; 2023; 53(5):1205-1213. PubMed ID: 38813014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune modulation as a consequence of SARS-CoV-2 infection.
    Gelmez MY; Oktelik FB; Tahrali I; Yilmaz V; Kucuksezer UC; Akdeniz N; Cetin EA; Kose M; Cinar C; Oguz FS; Besisik S; Koksalan K; Ozdemir O; Senkal N; Gul A; Tuzun E; Deniz G
    Front Immunol; 2022; 13():954391. PubMed ID: 36110850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
    Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
    Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19.
    Bergantini L; d'Alessandro M; Cameli P; Cavallaro D; Gangi S; Cekorja B; Sestini P; Bargagli E
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.